EditorialIi1TOBACCO CONTROLDecember 2004 Vol. 13 <strong>Su</strong>pplem<strong>en</strong>t IIThe tobacco industry in Asia: revelations in thecorporate docum<strong>en</strong>ts J M MackayResearch papersii4"Care and feeding": the Asian <strong>en</strong>vironm<strong>en</strong>taltobacco smoke consultants programmeM Assunta, N Fields, j Knight, S Chapmanii13 "A phony way to show sincerity, as we all well know":tobacco industry lobbying against tobacco control inHong Kong j Knight, S Chapmanii22 "Asian yuppies...are always looking for something newand differ<strong>en</strong>t": creating a tobacco culture among youngAsians J Knight, S Chapmanii30 "Asia is now the priority target for the world anti-tobaccomovem<strong>en</strong>t": attempts by the tobacco industry toun<strong>de</strong>rmine the Asian anti-smoking movem<strong>en</strong>t J Knight,S Chapmanii37 Industry sponsored youth smoking prev<strong>en</strong>tionprogramme in Malaysia: a case study in duplicityM Assunta, S Chapmanii43 A mire of highly subjective and ineffective voluntarygui<strong>de</strong>lines: tobacco industry efforts to thwart tobaccocontrol in Malaysia M Assunta, S Chapmanii51 'The world 's most hostile<strong>en</strong>vironm<strong>en</strong>t": how the tobacco industry circumv<strong>en</strong>tedSingapore's advertising ban M Assunta, S Chapmanii58ii63ii71ii79ii88ii96A “clean cigarette" for a clean nation: a case studyof Salem Pianissimo in Japan M Assunta,S ChapmanThe tobacco industry's accounts of refining indirecttobacco advertising in Malaysia M Assunta, SChapmanThe Philippine tobacco industry: "the strongest tobaccolobby in Asia"K Alechnowicz, S Chapman"If we can just 'stall' new unfri<strong>en</strong>dly legislations, thescoreboard is already in our favour": transnationaltobacco companies and ingredi<strong>en</strong>ts disclosure inThailand R MacK<strong>en</strong>zie, J Collin, K Sriwongcharo<strong>en</strong>, ME MuggliBreaking and re-<strong>en</strong>tering: BritishAmerican Tobacco in China1 979-2000 K Lee, A B Gilmore, J CollinCompeting with kreteks: transnational tobaccocompanies, globalisation, and Indonesia S Lawr<strong>en</strong>ce,J Collinii104 Complicity in contraband: British American Tobacco andcigarette smuggling ¡n Asia J Collin, E LeGresley, RMacK<strong>en</strong>zie, S Lawr<strong>en</strong>ce, K Leeii112 "Almost a role mo<strong>de</strong>l of what wewould like to do everywhere": British American Tobaccoin Cambodia R MacK<strong>en</strong>zie, J Collin, C Sopharo, YSopheapii118 ARTIST (Asian regional tobaccoindustry sci<strong>en</strong>tist team): Philip Morris' attempt to exert asci<strong>en</strong>tific and regulatory ag<strong>en</strong>da on AsiaE K Tong, S A Glantz
trastornosadictivosVolum<strong>en</strong> 6 • Número 3 • Julio-Septiembre 2004SUMARIOPáginasEDITORIAL / EDITORIALEl alcohol y sus acciones / The Research Society Alcoholism Lecture Series................................................147Y. IsraelDOCUMENTOS SET / SET DOCUMENTSPosicionami<strong>en</strong>tos <strong>de</strong> la SET ante cuestiones controvertidas <strong>en</strong> drogo<strong>de</strong>p<strong>en</strong>d<strong>en</strong>cias /SET position papers on drug <strong>de</strong>p<strong>en</strong>d<strong>en</strong>ce issues.........................................................…………..…149ÁREA CLÍNICA / CLINIC SECTIONSignos físicos <strong>de</strong>l uso <strong>de</strong> drogas inyectables <strong>en</strong>tre <strong>de</strong>funciones <strong>de</strong> la frontera norte <strong>de</strong> México / Physicalsigns of the drug use injectable betwe<strong>en</strong> <strong>de</strong>aths of the northern bor<strong>de</strong>r of Mexico...................................151N. Linares PérezUn mo<strong>de</strong>lo <strong>de</strong> tratami<strong>en</strong>to psicoterapéutico <strong>en</strong> adicciones. / A psychotherapy treatm<strong>en</strong>t mo<strong>de</strong>lin addictions. ........................................................................................................................................159E. Sánchez-Hervás, V. Tomás Gradolí, E. Morales GallúsConc<strong>en</strong>traciones plasmáticas <strong>de</strong> metadona: su relación con las condiciones clínicas y con los consumos<strong>de</strong> sustancias <strong>de</strong> abuso <strong>de</strong> los paci<strong>en</strong>tes <strong>en</strong> programa <strong>de</strong> mant<strong>en</strong>imi<strong>en</strong>to con metadona / Plasmalevels of methadone: their relationship with the clinical conditions and consumption of abusesubstances of pati<strong>en</strong>ts in the methadone maint<strong>en</strong>ance program........................................................167C. <strong>de</strong>l Pino Lidón y P. Varas SolerÁREA DE PSICOPATOLOGÍA / PSYCHOPATHOLOGY SECTIONEvolución <strong>de</strong> la sintomatología psicopatológica <strong>de</strong> los drogo<strong>de</strong>p<strong>en</strong>di<strong>en</strong>tes a lo largo <strong>de</strong>l tratami<strong>en</strong>to/Evolution of psycopathologic symptoms of drug <strong>de</strong>p<strong>en</strong>d<strong>en</strong>ts throughout the treatm<strong>en</strong>t..........................176E.J. Pedrero Pérez, C. Puerta García, I. Segura López y S.M. Osorio <strong>de</strong>l RíoTrastorno por déficit <strong>de</strong> at<strong>en</strong>ción e hiperactividad y su relación con rasgos y trastornos <strong>de</strong>personalidad <strong>en</strong> consumidores <strong>de</strong> drogas <strong>en</strong> tratami<strong>en</strong>to: estudio <strong>de</strong>l WURS y su relacióncon el BFQ y el MCMI-II. Una visión crítica / Att<strong>en</strong>tion <strong>de</strong>ficit hyperactivity disor<strong>de</strong>rand its relationship with personality disor<strong>de</strong>rs and traits in drug consumers un<strong>de</strong>r treatm<strong>en</strong>t:WURS study and its relationship with the BFQ and the MCMI-II. A critical view………………..192E.J. Pedrero Pérez, C. Puerta García, A. Olivar Arroyo, A. Lagares Roibas y M. Pérez LópezNOTICIAS / NEWS........................................................................................................................213AUTOEVALUACIÓN Y FORMACIÓN CONTINUADA EN TRASTORNOSADICTIVOS / AUTOEVALUATION AND CONTINUING EDUCATION ABOUT..………….217
- Page 1 and 2:
Su elaboración en formato electró
- Page 3 and 4:
Tabaco.............................
- Page 5 and 6:
• VALLEJO RUILOBA J. (2003). UPDA
- Page 7 and 8:
• HENNINGFIELD J.E., BENOWITZ N.L
- Page 9 and 10:
• PLASSE T. (2003). EFECTOS ENTIE
- Page 11 and 12:
• LOWENFELS A.B., MAISONNEUVE P.
- Page 13 and 14:
• COMISION EUROPEA. HEALTH STATIS
- Page 15 and 16:
• ZATONSKI W. (2004). TOBACCO SMO
- Page 17 and 18:
• IRALA ESTEVEZ J. DE, MARTINEZ G
- Page 19 and 20:
• EUROPOL. UNIDAD DE DROGAS. (200
- Page 21 and 22:
• CHESHER G.B., LONGO M. (2003).
- Page 23 and 24:
• MCPARTLAND J.M. (2003). CONTAMI
- Page 25 and 26:
• SWIFT W., HALL W. (2003). CANNA
- Page 27 and 28:
• PLAZA GARCIA I. (2004). PROGRAM
- Page 29 and 30:
• GARRETT B. E., DWOSKIN L., BARD
- Page 31 and 32:
• LEVI F., VECCHIA C. LA. (2004).
- Page 33 and 34:
• WHITE P. (2004). TOBACCO IN GRE
- Page 35 and 36:
Psicoterapia• AMERICAN PSYCHIATRI
- Page 37 and 38:
• MEXICO. CONSEJO NACIONAL CONTRA
- Page 39 and 40:
BOE 20/10/2004MINISTERIO DE SANIDAD
- Page 41 and 42:
Addiction .........................
- Page 43 and 44:
AddictionVOLUME 99 • NUMBER 10
- Page 45 and 46:
AddictionVOLUME 99 • SUPPLEMENT 2
- Page 47 and 48:
ADDICTION RESEARCH & THEORYVolume 1
- Page 49 and 50:
ADDICTIVE BEHAVIORSAN INTERNATIONAL
- Page 51 and 52:
ADDICTIVE BEHAVIORSAN INTERNATIONAL
- Page 53 and 54:
ADDICTIVE BEHAVIORSVol. 29, No. 8,
- Page 55 and 56:
Continued from outside back coverAD
- Page 57 and 58:
CDD DDZCentro de Documentaciónde d
- Page 59 and 60: CDD DDZCentro de Documentaciónde d
- Page 61 and 62: DRUG and ALCOHOLDEPENDENCEVolume 76
- Page 63 and 64: Drugs: education, prevention and po
- Page 65 and 66: EuropeanAddictionResearch 10/3/04Re
- Page 67 and 68: Depression, Negative Self-Image, an
- Page 69 and 70: The Dynamic Nature of Risk Factors
- Page 71 and 72: esults indicated acceptable model f
- Page 73 and 74: eceive either the Intervention or s
- Page 75 and 76: Volume 34, Number 1 — 2004JOURNAL
- Page 77 and 78: Journal of Psychoactive DrugsVolume
- Page 79 and 80: Contents (continued)DAWSON, D.A., G
- Page 81 and 82: Contents (continued)SATRE, D.D., ME
- Page 83 and 84: Volume 27/Number 3Journal of Substa
- Page 85 and 86: PROCESOS DE CAMBIO EN EL TRATAMIENT
- Page 87 and 88: PSYCHOLOGY OFADDICTIVE BEHAVIORSVol
- Page 89 and 90: PUBLIC HEALTH ReportVOLUME 119 NUMB
- Page 91 and 92: RETrevista de toxicomanías nº 39
- Page 93 and 94: SUBSTANCE USE & MISUSEVolume 39, Nu
- Page 95 and 96: SUBSTANCE USE & MISUSEVolume 39, Nu
- Page 97 and 98: SUBSTANCE USE & MISUSEVolume 39, Nu
- Page 99 and 100: SUBSTANCE USE & MISUSE, 39 (10-12),
- Page 101 and 102: SUBSTANCE USE & MISUSE, 39 (13 & 14
- Page 103 and 104: THE AMERICAN JOURNAL OF DRUG AND AL
- Page 105 and 106: THE AMERICAN JOURNAL OF DRUG AND AL
- Page 107 and 108: THEAMERICANJOURNAL ONADDICTIONSVOLU
- Page 109: TOBACCO CONTROLDecember 2004 Vol. 1